Live Report · Updated January 26, 2026

Colgate-Palmolive vs Corteva

This page compares Colgate-Palmolive Co. and Corteva, Inc., examining their business models, financial performance, and market context in a neutral, accessible way. It outlines how each company creates value, manages operations, and navigates its industry environment for readers seeking a balanced view. Educational content, not financial advice.

This page compares Colgate-Palmolive Co. and Corteva, Inc., examining their business models, financial performance, and market context in a neutral, accessible way. It outlines how each company create...

Comparison Snapshot

Key Financial Metrics

CL

Metric

CTVA

$68.68B

Market Cap

$49.08B

2.50%

Potential Profit

5.81%

Buy

Analyst Rating

Buy

Why It's Moving

Colgate-Palmolive Draws Mixed Analyst Views Ahead of Pivotal Q4 Earnings

JPMorgan hiked its target to $93 with an Overweight rating, betting on plain-vanilla stability despite mixed U.S. consumer signals in the sector preview.
TD Cowen cut to $86 but held Buy, warning of a tough 2026 with weak volume growth echoing last year's -0.9% dip.
Ex-dividend action hit January 21, delivering $0.52 per share to holders, underscoring CL's appeal as a dividend stalwart in uncertain times.

Sentiment:

⚖️Neutral

Corteva Surges on Analyst Upgrades Amid Undervaluation Buzz and Growth Tailwinds

Analysts raised price targets to $81, citing expectations for higher U.S. corn volumes and industry tailwinds that could boost revenues and market share.
Innovation advancements like Vorceed traits and gene editing promise premium pricing and improved margins, framing the stock as 8-10% undervalued at fair value estimates around $78.
Recent 6% 30-day gains reflect momentum from expansion in Latin America and Asia-Pacific, offsetting PFAS class action concerns from a Montana court decision.

Sentiment:

🐃Bullish

Colgate-Palmolive Draws Mixed Analyst Views Ahead of Pivotal Q4 Earnings

JPMorgan hiked its target to $93 with an Overweight rating, betting on plain-vanilla stability despite mixed U.S. consumer signals in the sector preview.
TD Cowen cut to $86 but held Buy, warning of a tough 2026 with weak volume growth echoing last year's -0.9% dip.
Ex-dividend action hit January 21, delivering $0.52 per share to holders, underscoring CL's appeal as a dividend stalwart in uncertain times.

Sentiment:

⚖️Neutral

Corteva Surges on Analyst Upgrades Amid Undervaluation Buzz and Growth Tailwinds

Analysts raised price targets to $81, citing expectations for higher U.S. corn volumes and industry tailwinds that could boost revenues and market share.
Innovation advancements like Vorceed traits and gene editing promise premium pricing and improved margins, framing the stock as 8-10% undervalued at fair value estimates around $78.
Recent 6% 30-day gains reflect momentum from expansion in Latin America and Asia-Pacific, offsetting PFAS class action concerns from a Montana court decision.

Sentiment:

🐃Bullish

Investment Analysis

Colgate-Palmolive

CL

Pros

Reported revenue growth of 3.31% in 2024, reaching $20.10 billion, demonstrating steady top-line expansion.
Maintains a strong dividend yield around 2.7%, offering consistent income for investors.
Has a well-established global presence with diversified segments in Oral, Personal and Home Care, and Pet Nutrition.

Considerations

Relatively high debt-to-equity ratio raises concerns about financial leverage and risk.
Stock price has shown limited appreciation over the past year, which may deter growth-focused investors.
Valuation indicated by a P/E ratio around 22 could be considered high compared to peers, limiting upside potential.

Corteva

CTVA

Pros

Operates in the agricultural sector with exposure to crop protection and seed products, aligning with global food demand growth.
Has a sizable market capitalization and revenue base, supporting operational scale and resource investment.
Analyst sentiment includes buy recommendations, reflecting confidence in growth prospects and strategic positioning.

Considerations

Stock price volatility remains a concern due to commodity price sensitivity and environmental regulatory risks.
Exposure to cyclical agricultural markets imposes earnings unpredictability linked to weather and global trade dynamics.
Execution risks exist in integrating research and development to maintain competitive product pipelines.

Related Market Insights

Why Familiar Brands Could Be Your Gateway to Stock Market Success

Nervous about investing? Discover how familiar consumer brands like Coca-Cola, PepsiCo & Ambev offer stability, dividends, and an accessible entry point to the stock market. Start with Nemo from £1.